HEPAMED
Dead / Cancelled — Cancelled — Section 8 (as of 09 May 2014)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78708610
- Registration number
- 3303902
- Mark type
- Stylized text
- Filed
- 07 Sept 2005
- Published for opposition
- 11 Jul 2006
- Registered
- 02 Oct 2007
- Attorney of record
- Erik M. Pelton
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of liver cancer and melanoma, namely arginine deiminase and derivatives thereof
Owner
- PROLONG PHARMACEUTICALS, LLC, SOUTH PLAINFIELD, NJ, US
- Prolong Pharmaceuticals, Inc., Monmouth Junction, NJ, US
- Prolong Pharmaceuticals, Inc., Monmouth Junction, NJ, US
- Prolong Pharmaceuticals, Inc., Monmouth Junction, NJ, US
Prosecution history
- 09 May 2014 — CANCELLED SEC. 8 (6-YR)
- 22 Dec 2010 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Oct 2007 — REGISTERED-PRINCIPAL REGISTER
- 29 Aug 2007 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 29 Aug 2007 — ASSIGNED TO LIE
- 19 Jul 2007 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2007 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Mar 2007 — USE AMENDMENT FILED
- 19 Mar 2007 — PAPER RECEIVED
- 03 Oct 2006 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 11 Jul 2006 — PUBLISHED FOR OPPOSITION
- 21 Jun 2006 — NOTICE OF PUBLICATION
- 25 May 2006 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 18 May 2006 — ASSIGNED TO LIE
- 01 May 2006 — APPROVED FOR PUB - PRINCIPAL REGISTER